Impact of a National Cancer Prevention and Treatment Program on the Prevalence of Late-Stage Breast Cancer Diagnoses in Oklahoma.

Amanda Janitz, Aaron M Wendelboe, Ann F Chou, Summer Frank, Angela Watkins, David Thompson, Janis Campbell

Abstract read

In one paragraph

Article in The Journal of the Oklahoma State Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amanda JanitzDepartment of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center.

Aaron M WendelboeDepartment of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center.

Ann F ChouDepartment of Health Administration and Policy, College of Public Health, University of Oklahoma Health Sciences Center.

Summer FrankOklahoma Tobacco Research Center.

Angela WatkinsUnited Health Group.

David ThompsonDepartment of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center.

Janis CampbellThe University of Oklahoma Health Sciences Center.

Funding

University of Oklahoma Community Networks Project OUCNPU01CA114626 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CAMPBELL, JANIS E · 2005 to 2010

$2.8M

NCI NIH HHS U01 CA114626

6 · The paper itself

Abstract

In 2000, Congress passed the Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) to provide coverage through Medicaid to women who screened positive for breast and cervical cancer. We aimed to determine if late-stage breast cancer prevalence decreased among Oklahoma women after passage of BCCPTA. Data were obtained from the Oklahoma Central Cancer Registry during 2000-2011. We estimated prevalence proportion ratios (PPR) using modified Poisson regression between the proportion of women with late-stage breast cancer and timing of diagnosis related to BCCPTA. Among uninsured women, the probability of being diagnosed with late-stage cancer after enactment of the BCCPTA was 0.80 (95% CI: 0.67, 0.96) times the probability before enactment. This was significant among uninsured women living in metro counties (PPR: 0.74, 95% CI: 0.61, 0.90) but not in non-metro counties (PPR: 1.05, 95% CI: 0.71, 1.56). These findings may be similar to other rural states with large uninsured populations.

Indexed as

AgedBreast NeoplasmsDelayed DiagnosisEarly Detection of CancerFemaleHumansMedicaidMedically UninsuredMiddle AgedOklahomaPrevalenceRegistriesUnited States

Identifiers

PMID27885306

PMCPMC5119628

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.